 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.             *sb0124*      
SENATE BILL 124  
J1   6lr1392  
SB 911/24 – FIN (PRE –FILED)    
By: Senator Benson  
Requested: October 28, 2025  
Introduced and read first time: January 14, 2026  
Assigned to: Finance  
 
A BILL ENTITLED  
 
AN ACT concerning  1 
 
Food, Drugs, and Cosmetics – Gene Structure – and Function –Modifying 2 
Products – Labeling  3 
 
FOR the purpose of prohibiting a person from offering for sale in the State a gene  4 
structure – or function –modifying product unless the product is labeled in a certain 5 
manner; and generally relating to labeling of gene structure – and  6 
function –modifying products.  7 
 
BY adding to  8 
 Article – Health – General  9 
Section 21 –2G–01 through 21 –2G–04 to be under the new subtitle “Subtitle 2G. Gene 10 
Structure – and Function –Modifying Products”  11 
 Annotated Code of Maryland  12 
 (2023 Replacement Volume  and 2025 Supplement ) 13 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 14 
That the Laws of Mary land read as follows:  15 
 
Article – Health – General  16 
 
SUBTITLE 2G. GENE STRUCTURE – AND FUNCTION –MODIFYING PRODUCTS . 17 
 
21–2G–01. 18 
 
 (A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE  THE MEANINGS 19 
INDICATED . 20 
 
 (B) “GENE STRUCTURE – OR FUNCTION –MODIFYING PRODUCT ” MEANS A 21 
PRODUCT THAT HAS BEE N PRODUCED USING MOD ERN BIOTECHNOLOGY ME THODS 22 
2 SENATE BILL 124   
 
 DESIGNED TO ALTER TH E STRUCTURE OR FUNCT ION OF ONE OR MORE G ENES IN THE 1 
PRODUCT AND WHICH LE ADS TO THE PRODUCT C ONTAINING ARTIFICIAL LY 2 
ENGINEERED ELEMENTS THAT MAY MODIFY THE STRUCTURE OR FUNCTIO N OF ONE 3 
OR MORE GENES IN A C ONSUMER . 4 
 
 (C) (1) “MODERN BIOTECHNOLOGY METHODS ” MEANS A RECENTLY 5 
DISCOVERED METHOD OF  APPLICATION OF BIOLO GICAL PROCESSES FOR 6 
INDUSTRIAL AND OTHER  PURPOSES . 7 
 
  (2) “MODERN BIOTECHNOLOGY METHODS ” INCLUDES : 8 
 
   (I) GENE EDITING ; 9 
 
   (II) RNA  INTERFERENCE ; AND 10 
 
   (III) TRANSGENESIS . 11 
 
21–2G–02. 12 
 
 (A) A PERSON MAY NOT OFFER  FOR SALE IN THE STATE A GENE 13 
STRUCTURE – OR FUNCTION –MODIFYING PRODUCT UN LESS THE GENE  14 
STRUCTURE – OR FUNCTION –MODIFYING PRODUCT IS  LABELED IN ACCORDANC E 15 
WITH SUBSECTION (B) OF THIS SECTION . 16 
 
 (B) A GENE STRUCTURE – OR FUNCTION –MODIFYING PRODUCT OF FERED 17 
FOR SALE IN THE STATE SHALL BE LABELE D, IN A PROMINENT AND C ONSPICUOUS 18 
MANNER , WITH : 19 
 
  (1) THE WORDS “GENE STRUCTURE – OR FUNCTION –MODIFYING 20 
PRODUCT ”; AND 21 
 
  (2) ALL POTENTIAL RISKS , SIDE EFFECTS , ADVERSE EFFECTS , AND 22 
OTHER REASONABLY POS SIBLE EFFECTS THAT T HE GENE STRUCTURE – OR 23 
FUNCTION –MODIFYING PRODUCT MA Y HAVE ON AN INDIVID UAL WHO USES THE 24 
GENE STRUCTU RE– OR FUNCTION –MODIFYING PRODUCT , OR ON AN INDIVIDUAL 25 
WHO MAY COME INTO CO NTACT WITH THE INDIV IDUAL WHO USES THE  26 
GENE STRUCTURE – OR FUNCTION –MODIFYING PRODUCT . 27 
 
21–2G–03. 28 
 
 (A) A PERSON THAT VIOLATES  THIS SUBTITLE : 29 
 
 SENATE BILL 124  3 
 
   (1) IS GUILTY OF A MISDEM EANOR AND O N CONVICTION IS SUBJ ECT 1 
TO: 2 
 
   (I) FOR A FIRST OFFENSE , A FINE NOT EXCEEDING  $10,000  OR 3 
IMPRISONMENT NOT EXC EEDING 1 YEAR ; AND 4 
 
   (II) FOR A SECOND OR SUBSE QUENT OFFENSE , A FINE NOT 5 
EXCEEDING $25,000  OR IMPRISONMENT NOT EXCEEDING 3 YEARS ; 6 
 
  (2) IS SUBJE CT TO A CIVIL PENALT Y NOT EXCEEDING $5,000  IN AN 7 
ACTION IN A DISTRICT COURT ; AND 8 
 
  (3) MAY BE ENJOINED FROM CONTINUING THE VIOLA TION . 9 
 
 (B) EACH DAY ON WHICH A V IOLATION OCCURS AFTE R CONVICTION FOR A 10 
FIRST OFFENSE IS A S EPARATE VIOLATION UN DER THIS SECTION . 11 
 
21–2G–04. 12 
 
 THIS SUBTITLE SHALL B E CONSTRUED LIBERALL Y TO CARRY OUT ITS 13 
PURPOSE . 14 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 15 
October 1, 2026 . 16 
 